BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21343376)

  • 1. Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method.
    van Leeuwen RW; Swart EL; Boven E; Boom FA; Schuitenmaker MG; Hugtenburg JG
    Ann Oncol; 2011 Oct; 22(10):2334-41. PubMed ID: 21343376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs.
    van Leeuwen RW; Brundel DH; Neef C; van Gelder T; Mathijssen RH; Burger DM; Jansman FG
    Br J Cancer; 2013 Mar; 108(5):1071-8. PubMed ID: 23412102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.
    Popa MA; Wallace KJ; Brunello A; Extermann M; Balducci L
    J Geriatr Oncol; 2014 Jul; 5(3):307-14. PubMed ID: 24821377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
    van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
    Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice.
    Escudero-Vilaplana V; Collado-Borrell R; Hoyo-Muñoz A; Gimenez-Manzorro A; Calles A; Osorio S; Herranz-Alonso A; Sanjurjo-Sáez M
    Expert Opin Drug Saf; 2020 Aug; 19(8):1041-1048. PubMed ID: 32529857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
    Prely H; Herledan C; Caffin AG; Baudouin A; Larbre V; Maire M; Schwiertz V; Vantard N; Ranchon F; Rioufol C
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):707-718. PubMed ID: 33914124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients.
    Lemachatti J; Levêque D; Beretz L; Bergerat JP
    Anticancer Res; 2009 Nov; 29(11):4741-4. PubMed ID: 20032429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with drug interactions in elderly hospitalized in high complexity hospital.
    Veloso RCSG; Figueredo TP; Barroso SCC; Nascimento MMGD; Reis AMM
    Cien Saude Colet; 2019 Jan; 24(1):17-26. PubMed ID: 30698236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence study on potential drug-drug interaction in cancer patients in Piacenza hospital's Onco-Haematology department.
    Vecchia S; Orlandi E; Confalonieri C; Damonti E; Riva A; Sartori A; Cavanna L
    J Oncol Pharm Pract; 2018 Oct; 24(7):490-493. PubMed ID: 28714379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort.
    Beinse G; Reitter D; Segaux L; Carvahlo-Verlinde M; Rousseau B; Tournigand C; Cudennec T; Laurent M; Boudou-Rouquette P; Paillaud E; Canouï-Poitrine F; Caillet P;
    J Geriatr Oncol; 2020 May; 11(4):586-592. PubMed ID: 31445850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions in oncology.
    Beijnen JH; Schellens JH
    Lancet Oncol; 2004 Aug; 5(8):489-96. PubMed ID: 15288238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug interactions and duplicate prescriptions among cancer patients.
    Riechelmann RP; Tannock IF; Wang L; Saad ED; Taback NA; Krzyzanowska MK
    J Natl Cancer Inst; 2007 Apr; 99(8):592-600. PubMed ID: 17440160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide prevalence of potential drug-drug interactions associated with non-anticancer agents in patients on oral anticancer agents in South Korea.
    Song YK; Oh JM
    Support Care Cancer; 2020 Aug; 28(8):3711-3720. PubMed ID: 31820128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication surveillance on intravenous cytotoxic agents: a retrospective study.
    van Oijen B; Janknegt R; de Wit H; Peters F; Schouten H; van der Kuy H
    Int J Clin Pharm; 2013 Aug; 35(4):554-9. PubMed ID: 23585184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs.
    Arora S; Roxburgh A; Bruno R; Nielsen S; Burns L
    Drug Alcohol Rev; 2013 Nov; 32(6):574-81. PubMed ID: 23751176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing patients' information needs regarding drug-drug interactions.
    Mutebi A; Warholak TL; Hines LE; Plummer R; Malone DC
    J Am Pharm Assoc (2003); 2013; 53(1):39-45. PubMed ID: 23636154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential drug-drug interactions in hospitalized patients undergoing systemic chemotherapy: a prospective cohort study.
    Stoll P; Kopittke L
    Int J Clin Pharm; 2015 Jun; 37(3):475-84. PubMed ID: 25711852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential drug interactions in patients with a history of cancer.
    Chen L; Cheung WY
    Curr Oncol; 2014 Apr; 21(2):e212-20. PubMed ID: 24764706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review.
    Clairet AL; Boiteux-Jurain M; Curtit E; Jeannin M; Gérard B; Nerich V; Limat S
    Med Oncol; 2019 Apr; 36(5):45. PubMed ID: 30993543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-medication with over the counter drugs, prevalence of risky practice and its associated factors in pharmacy outlets of Asmara, Eritrea.
    Tesfamariam S; Anand IS; Kaleab G; Berhane S; Woldai B; Habte E; Russom M
    BMC Public Health; 2019 Feb; 19(1):159. PubMed ID: 30727984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.